T lymphoreceptopathy in systemic lupus erythematosus

Area of Science:

• Immunology
• Cell Biology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
• T lymphocytes play a crucial role in immune responses and their dysfunction is implicated in SLE pathogenesis.
• Lymphoreceptopathy, a condition affecting T lymphocytes, has been observed in SLE patients.

Purpose of the Study:

• To investigate the decreased numbers and functions of T lymphocytes in SLE patients, termed lymphoreceptopathy.
• To explore the effects of suppressor T cells and Concanavalin A (Con A) induced suppressor factor on antibody formation in SLE.
• To analyze changes in T lymphocyte membrane microviscosity and membrane-associated particles (MAPs) in SLE.

Main Methods:

• Analysis of T lymphocytes and sera from SLE patients and healthy controls.
• Assessment of suppressor T cell activity and Con A induced suppressor factor.
• Measurement of T lymphocyte membrane microviscosity.
• Electron microscopy to study the ultrastructure of membrane-associated particles (MAPs).

Main Results:

• SLE T lymphocytes exhibit decreased function and numbers, indicative of lymphoreceptopathy.
• Reduced membrane microviscosity and abnormal distribution, size, and density of MAPs on T lymphocytes were observed in SLE.
• Serum factors, primarily IgG (T cell membrane binding antibody) and IgM (cytotoxic antibody), modulate SLE T lymphocyte lymphoreceptopathy.

Conclusions:

• SLE T lymphocyte lymphoreceptopathy is associated with decreased membrane microviscosity and aberrant MAPs.
• Serum autoantibodies, particularly IgG and IgM, contribute to the modulation of T lymphocyte dysfunction in SLE.
• These findings provide insights into the cellular and molecular mechanisms underlying T cell abnormalities in SLE.